Glaucoma eye drops adverse skin reactions

Carmen Cantisani, Marina Ambrifi, Federica Frascani, Gilda Fazia, Giovanni Paolino, Roberto Lisi, Stefano Calvieri

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The term “Glaucoma” is used to describe a number of diseases of the eye characterized by a particular form of optic nerve damage that is often associated with high intraocular pressure (IOP). The open-angle glaucoma is the most common form that is also referred to as chronic glaucoma. This is described as an optic neuropathy with multifactorial nature in which there is a loss of characteristics of the optic nerve fibers. Therapeutic options for the treatment of this disease are different, you can take advantage of eye drops, laser therapy and conventional surgery or more combined treatments. Medicated eye drops are the most common way to treat glaucoma. Although eye drops are widely used, adverse reactions are not frequently observed and described. In particular, the adverse skin reactions are not frequently described in the literature, but often seen in dermatologic clinic, we reported their skin reactions and possible alternative treatments described in literature and their patent applications.

Original languageEnglish
Pages (from-to)192-195
Number of pages4
JournalRecent Patents on Inflammation and Allergy Drug Discovery
Volume8
Issue number3
Publication statusPublished - Jan 1 2014

Fingerprint

Ophthalmic Solutions
Glaucoma
Skin
Optic Nerve
Optic Nerve Diseases
Eye Diseases
Open Angle Glaucoma
Laser Therapy
Therapeutics
Intraocular Pressure
Nerve Fibers

Keywords

  • Beta-blockers
  • Eye drop
  • Glaucoma
  • High intraocular pressure
  • Ocular disorders
  • Skin reactions

ASJC Scopus subject areas

  • Drug Discovery
  • Immunology and Allergy
  • Medicine(all)

Cite this

Cantisani, C., Ambrifi, M., Frascani, F., Fazia, G., Paolino, G., Lisi, R., & Calvieri, S. (2014). Glaucoma eye drops adverse skin reactions. Recent Patents on Inflammation and Allergy Drug Discovery, 8(3), 192-195.

Glaucoma eye drops adverse skin reactions. / Cantisani, Carmen; Ambrifi, Marina; Frascani, Federica; Fazia, Gilda; Paolino, Giovanni; Lisi, Roberto; Calvieri, Stefano.

In: Recent Patents on Inflammation and Allergy Drug Discovery, Vol. 8, No. 3, 01.01.2014, p. 192-195.

Research output: Contribution to journalArticle

Cantisani, C, Ambrifi, M, Frascani, F, Fazia, G, Paolino, G, Lisi, R & Calvieri, S 2014, 'Glaucoma eye drops adverse skin reactions', Recent Patents on Inflammation and Allergy Drug Discovery, vol. 8, no. 3, pp. 192-195.
Cantisani C, Ambrifi M, Frascani F, Fazia G, Paolino G, Lisi R et al. Glaucoma eye drops adverse skin reactions. Recent Patents on Inflammation and Allergy Drug Discovery. 2014 Jan 1;8(3):192-195.
Cantisani, Carmen ; Ambrifi, Marina ; Frascani, Federica ; Fazia, Gilda ; Paolino, Giovanni ; Lisi, Roberto ; Calvieri, Stefano. / Glaucoma eye drops adverse skin reactions. In: Recent Patents on Inflammation and Allergy Drug Discovery. 2014 ; Vol. 8, No. 3. pp. 192-195.
@article{6b0120ec7b2d4b6e841ef28ab6dfbe35,
title = "Glaucoma eye drops adverse skin reactions",
abstract = "The term “Glaucoma” is used to describe a number of diseases of the eye characterized by a particular form of optic nerve damage that is often associated with high intraocular pressure (IOP). The open-angle glaucoma is the most common form that is also referred to as chronic glaucoma. This is described as an optic neuropathy with multifactorial nature in which there is a loss of characteristics of the optic nerve fibers. Therapeutic options for the treatment of this disease are different, you can take advantage of eye drops, laser therapy and conventional surgery or more combined treatments. Medicated eye drops are the most common way to treat glaucoma. Although eye drops are widely used, adverse reactions are not frequently observed and described. In particular, the adverse skin reactions are not frequently described in the literature, but often seen in dermatologic clinic, we reported their skin reactions and possible alternative treatments described in literature and their patent applications.",
keywords = "Beta-blockers, Eye drop, Glaucoma, High intraocular pressure, Ocular disorders, Skin reactions",
author = "Carmen Cantisani and Marina Ambrifi and Federica Frascani and Gilda Fazia and Giovanni Paolino and Roberto Lisi and Stefano Calvieri",
year = "2014",
month = "1",
day = "1",
language = "English",
volume = "8",
pages = "192--195",
journal = "Recent Patents on Inflammation and Allergy Drug Discovery",
issn = "1872-213X",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Glaucoma eye drops adverse skin reactions

AU - Cantisani, Carmen

AU - Ambrifi, Marina

AU - Frascani, Federica

AU - Fazia, Gilda

AU - Paolino, Giovanni

AU - Lisi, Roberto

AU - Calvieri, Stefano

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The term “Glaucoma” is used to describe a number of diseases of the eye characterized by a particular form of optic nerve damage that is often associated with high intraocular pressure (IOP). The open-angle glaucoma is the most common form that is also referred to as chronic glaucoma. This is described as an optic neuropathy with multifactorial nature in which there is a loss of characteristics of the optic nerve fibers. Therapeutic options for the treatment of this disease are different, you can take advantage of eye drops, laser therapy and conventional surgery or more combined treatments. Medicated eye drops are the most common way to treat glaucoma. Although eye drops are widely used, adverse reactions are not frequently observed and described. In particular, the adverse skin reactions are not frequently described in the literature, but often seen in dermatologic clinic, we reported their skin reactions and possible alternative treatments described in literature and their patent applications.

AB - The term “Glaucoma” is used to describe a number of diseases of the eye characterized by a particular form of optic nerve damage that is often associated with high intraocular pressure (IOP). The open-angle glaucoma is the most common form that is also referred to as chronic glaucoma. This is described as an optic neuropathy with multifactorial nature in which there is a loss of characteristics of the optic nerve fibers. Therapeutic options for the treatment of this disease are different, you can take advantage of eye drops, laser therapy and conventional surgery or more combined treatments. Medicated eye drops are the most common way to treat glaucoma. Although eye drops are widely used, adverse reactions are not frequently observed and described. In particular, the adverse skin reactions are not frequently described in the literature, but often seen in dermatologic clinic, we reported their skin reactions and possible alternative treatments described in literature and their patent applications.

KW - Beta-blockers

KW - Eye drop

KW - Glaucoma

KW - High intraocular pressure

KW - Ocular disorders

KW - Skin reactions

UR - http://www.scopus.com/inward/record.url?scp=84920620556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920620556&partnerID=8YFLogxK

M3 - Article

C2 - 25487259

AN - SCOPUS:84920620556

VL - 8

SP - 192

EP - 195

JO - Recent Patents on Inflammation and Allergy Drug Discovery

JF - Recent Patents on Inflammation and Allergy Drug Discovery

SN - 1872-213X

IS - 3

ER -